Anti-phospholipid human monoclonal antibodies inhibit CCR5-tropic HIV-1 and induce β-chemokines

Journal of Experimental Medicine

Volumn 207, Issue 4, 2010, Pages 763-776

  Moody, M Anthony ^a   Liao, Hua Xin ^a   Alam, S Munir ^a   Scearce, Richard M ^a   Plonk, M Kelly ^a   Kozink, Daniel M ^a   Drinker, Mark S ^a   Zhang, Ruijun ^a   Xia, Shi Mao ^a   Sutherland, Laura L ^a   Tomaras, Georgia D ^a   Giles, Ian P ^b   Kappes, John C ^c,d,e   Ochsenbauer Jambor, Christina ^c   Edmonds, Tara G ^d   Soares, Melina ^f   Barbero, Gustavo ^f   Forthal, Donald N ^g   Landucci, Gary ^g   Chang, Connie ^h   King, Steven W ^h   Kavlie, Anita ⁱ   Denny, Thomas N ^a   Hwang, Kwan Ki ^a   Chen, Pojen P ^j   Thorpe, Philip E ^f   Montefiori, David C ^a   Haynes, Barton F ^a   more..

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c University of Alabama at Birmingham   (United States)

^d University of Alabama at Birmingham   (United States)

^e BIRMINGHAM VA MEDICAL CENTER   (United States)

^f UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h Peregrine Pharmaceuticals Inc   (United States)

ⁱ Affitech AS   (Norway)

^j UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BETA CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCLONAL ANTIBODY; PHOSPHOLIPID ANTIBODY;

ARTICLE; CD4+ T LYMPHOCYTE; CELL CULTURE; DRUG EFFECT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; VIRUS INFECTION; VIRUS INHIBITION;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTIBODIES, MONOCLONAL; BETA 2-GLYCOPROTEIN I; CARDIOLIPINS; CD4-POSITIVE T-LYMPHOCYTES; CELL FUSION; CHEMOKINE CCL3; CHEMOKINE CCL4; CHEMOKINES; CHEMOKINES, CC; COMPLEMENTARITY DETERMINING REGIONS; CULTURE MEDIA, CONDITIONED; ENDOTOXINS; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; EPITHELIAL CELLS; GIANT CELLS; HIV-1; HUMANS; IMMUNITY, INNATE; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOGLOBULIN FC FRAGMENTS; KINETICS; LEUKOCYTES, MONONUCLEAR; MONOCYTES; MUTATION; PHOSPHATIDYLETHANOLAMINES; PHOSPHATIDYLSERINES; RECEPTORS, CCR5; VIRAL TROPISM; VIRUS INTERNALIZATION;

EID: 77951080820     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20091281     Document Type: Article

References (60)

1. Alam, S.M., M. McAdams, D. Boren, M. Rak, R.M. Scearce, F. Gao, Z.T. Camacho, D. Gewirth, G. Kelsoe, P. Chen, and B.F. Haynes. 2007. The role of antibody polyspecificity and lipid reactivity in binding of broadly neutralizing anti-HIV-1 envelope human monoclonal antibodies 2F5 and 4E10 to glycoprotein 41 membrane proximal envelope epitopes. J. Immunol. 178:4424-4435.
2. Alam, S.M., R.M. Scearce, R.J. Parks, K. Plonk, S.G. Plonk, L.L. Sutherland, M.K. Gorny, S. Zolla-Pazner, S. Vanleeuwen, M.A. Moody, et al. 2008. Human immunodeficiency virus type 1 gp41 antibodies that mask membrane proximal region epitopes: antibody binding kinetics, induction, and potential for regulation in acute infection. J. Virol. 82:115-125. doi:10.1128/JVI.00927-07
3. Alving, C.R. 2006. Antibodies to lipids and liposomes: immunology and safety. J. Liposome Res. 16:157-166. doi:10.1080/08982100600848553
4. Baba, T.W., V. Liska, R. Hofmann-Lehmann, J. Vlasak, W. Xu, S. Ayehunie, L.A. Cavacini, M.R. Posner, H. Katinger, G. Stiegler, et al. 2000. Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection. Nat. Med. 6:200-206. doi:10.1038/72309
5. Bernstein, H.B., A.L. Kinter, R. Jackson, and A.S. Fauci. 2004. Neonatal natural killer cells produce chemokines and suppress HIV replication in vitro. AIDS Res. Hum. Retroviruses. 20:1189-1195.
6. Bevers, E.M., P. Comfurius, and R.F. Zwaal. 1983. Changes in membrane phospholipid distribution during platelet activation. Biochim. Biophys. Acta. 736:57-66. doi:10.1016/0005-2736(83)90169-4 (Pubitemid 14201823)
7. Binley, J.M., E.A. Lybarger, E.T. Crooks, M.S. Seaman, E. Gray, K.L. Davis, J.M. Decker, D. Wycuff, L. Harris, N. Hawkins, et al. 2008. Profiling the specificity of neutralizing antibodies in a large panel of plasmas from patients chronically infected with human immunodeficiency virus type 1 subtypes B and C. J. Virol. 82:11651-11668. doi:10.1128/JVI.01762-08
8. Brown, B.K., N. Karasavvas, Z. Beck, G.R. Matyas, D.L. Birx, V.R. Polonis, and C.R. Alving. 2007. Monoclonal antibodies to phosphatidylinositol phosphate neutralize human immunodeficiency virus type 1: role of phosphate-binding subsites. J. Virol. 81:2087-2091. doi:10.1128/JVI.02011-06
9. Burton, D.R., R.L. Stanfield, and I.A. Wilson. 2005. Antibody vs. HIV in a clash of evolutionary titans. Proc. Natl. Acad. Sci. USA. 102:14943-14948. doi:10.1073/pnas.0505126102
10. Dolgin, E. 2009. Vaccine protects against HIV virus. Nature News. 10.1038/news.2009.947.
11. Douvas, A., and Y. Takehana. 1994. Cross-reactivity between autoimmune anti-U1 snRNP antibodies and neutralizing epitopes of HIV-1 gp120/41. AIDS Res. Hum. Retroviruses. 10:253-262. doi:10.1089/aid.1994.10.253 (Pubitemid 24116781)
12. Douvas, A., Y. Takehana, G. Ehresmann, T. Chernyovskiy, and E.S. Daar. 1996. Neutralization of HIV type 1 infectivity by serum antibodies from a subset of autoimmune patients with mixed connective tissue disease. AIDS Res. Hum. Retroviruses. 12:1509-1517. doi:10.1089/aid.1996.12.1509 (Pubitemid 26366909)
13. Dunlop, D.C., A. Ulrich, B.J. Appelmelk, D.R. Burton, R.A. Dwek, N. Zitzmann, and C.N. Scanlan. 2008. Antigenic mimicry of the HIV envelope by AIDS-associated pathogens. AIDS. 22:2214-2217. doi:10.1097/QAD.0b013e328314b5df
14. Ferbas, J., J.V. Giorgi, S. Amini, K. Grovit-Ferbas, D.J. Wiley, R. Detels, and S. Plaeger. 2000. Antigen-specific production of RANTES, macrophage inflammatory protein (MIP)-1α, and MIP-1β in vitro is a correlate of reduced human immunodeficiency virus burden in vivo. J. Infect. Dis. 182:1247-1250. doi:10.1086/315849
15. Fernández, N., M. Renedo, C. García-Rodríguez, and M. Sánchez Crespo. 2002. Activation of monocytic cells through Fc γ receptors induces the expression of macrophage-inflammatory protein (MIP)-1 α, MIP-1 β, and RANTES. J. Immunol. 169:3321-3328. (Pubitemid 35013181)
16. Forthal, D.N., G. Landucci, and E.S. Daar. 2001. Antibody from patients with acute human immunodeficiency virus (HIV) infection inhibits primary strains of HIV type 1 in the presence of natural-killer effector cells. J. Virol. 75:6953-6961. doi:10.1128/JVI.75.15.6953-6961.2001
17. Forthal, D.N., G. Landucci, T.B. Phan, and J. Becerra. 2005. Interactions between natural killer cells and antibody Fc result in enhanced antibody neutralization of human immunodeficiency virus type 1. J. Virol. 79:2042-2049. doi:10.1128/JVI.79.4.2042-2049.2005
18. Gasper-Smith, N., D.M. Crossman, J.F. Whitesides, N. Mensali, J.S. Ottinger, S.G. Plonk, M.A. Moody, G. Ferrari, K.J. Weinhold, S.E. Miller, et al. 2008. Induction of plasma (TRAIL), TNFR-2, Fas ligand, and plasma microparticles after human immunodeficiency virus type 1 (HIV-1) transmission: implications for HIV-1 vaccine design. J. Virol. 82:7700-7710. doi:10.1128/JVI.00605-08
19. Giles, I., N. Lambrianides, N. Pattni, D. Faulkes, D. Latchman, P. Chen, S. Pierangeli, D. Isenberg, and A. Rahman. 2006. Arginine residues are important in determining the binding of human monoclonal antiphospholipid antibodies to clinically relevant antigens. J. Immunol. 177:1729-1736.
20. Haynes, B.F., and A.S. Fauci. 1978. Activation of human B lymphocytes. VI. Immunoregulation of antibody production by mitogen-induced and naturally occurring cells in normal individuals. Cell. Immunol. 36:294-302. doi:10.1016/0008-8749(78)90273-3
21. Haynes, B.F., J. Fleming, E.W. St Clair, H. Katinger, G. Stiegler, R. Kunert, J. Robinson, R.M. Scearce, K. Plonk, H.F. Staats, et al. 2005. Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies. Science. 308:1906-1908. doi:10.1126/science.1111781
22. Hessell, A.J., L. Hangartner, M. Hunter, C.E. Havenith, F.J. Beurskens, J.M. Bakker, C.M. Lanigan, G. Landucci, D.N. Forthal, P.W. Parren, et al. 2007. Fc receptor but not complement binding is important in antibody protection against HIV. Nature. 449:101-104. doi:10.1038/nature06106
23. Ioannou, Y., I. Giles, A. Lambrianides, C. Richardson, L.H. Pearl, D.S. Latchman, D.A. Isenberg, and A. Rahman. 2006. A novel expression system of domain I of human beta2 glycoprotein I in Escherichia coli. BMC Biotechnol. 6:8. doi:10.1186/1472-6750-6-8
24. 2)-glycoprotein I: mutation studies including residues R39 to R43. Arthritis Rheum. 56:280-290. doi:10.1002/art.22306
25. 2-glycoprotein I to determine fine antigenic specificity of antiphospholipid autoantibodies. J. Immunol. 169:7097-7103.
26. Keele, B.F., E.E. Giorgi, J.F. Salazar-Gonzalez, J.M. Decker, K.T. Pham, M.G. Salazar, C. Sun, T. Grayson, S. Wang, H. Li, et al. 2008. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc. Natl. Acad. Sci. USA. 105:7552-7557. doi:10.1073/pnas.0802203105
27. Kinter, A., A. Catanzaro, J. Monaco, M. Ruiz, J. Justement, S. Moir, J. Arthos, A. Oliva, L. Ehler, S. Mizell, et al. 1998. CC-chemokines enhance the replication of T-tropic strains of HIV-1 in CD4(+) T cells: role of signal transduction. Proc. Natl. Acad. Sci. USA. 95:11880-11885. doi:10.1073/pnas.95. 20.11880
28. Levesque, M.C., M.A. Moody, K.K. Hwang, D.J. Marshall, J.F. Whitesides, J.D. Amos, T.C. Gurley, S. Allgood, B.B. Haynes, N.A. Vandergrift, et al. 2009. Polyclonal B cell differentiation and loss of gastrointestinal tract germinal centers in the earliest stages of HIV-1 infection. PLoS Med. 6:e1000107. doi:10.1371/journal.pmed.1000107
29. Li, Y., K. Svehla, M.K. Louder, D. Wycuff, S. Phogat, M. Tang, S.A. Migueles, X. Wu, A. Phogat, G.M. Shaw, et al. 2009. Analysis of neutralization specificities in polyclonal sera derived from human immunodeficiency virus type 1-infected individuals. J. Virol. 83:1045-1059. doi:10.1128/JVI.01992-08
30. Liao, H.X., L.L. Sutherland, S.M. Xia, M.E. Brock, R.M. Scearce, S. Vanleeuwen, S.M. Alam, M. McAdams, E.A. Weaver, Z. Camacho, et al. 2006. A group M consensus envelope glycoprotein induces antibodies that neutralize subsets of subtype B and C HIV-1 primary viruses. Virology. 353:268-282. doi:10.1016/j.virol.2006.04.043
31. 2-glycoprotein I and the homologous catalytic domains of several serine proteases. Arthritis Rheum. 56:1638-1647. doi:10.1002/art.22522
32. Maeda, K., M. Matsuda, H. Suzuki, and H.A. Saitoh. 2002. Immunohistochemical recognition of human follicular dendritic cells (FDCs) in routinely processed paraffin sections. J. Histochem. Cytochem. 50:1475-1486.
33. Mascola, J.R., G. Stiegler, T.C. VanCott, H. Katinger, C.B. Carpenter, C.E. Hanson, H. Beary, D. Hayes, S.S. Frankel, D.L. Birx, and M.G. Lewis. 2000. Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat. Med. 6:207-210. doi:10.1038/72318
34. Mascola, J.R., P. D'Souza, P. Gilbert, B.H. Hahn, N.L. Haigwood, L. Morris, C.J. Petropoulos, V.R. Polonis, M. Sarzotti, and D.C. Montefiori. 2005a. Recommendations for the design and use of standard virus panels to assess neutralizing antibody responses elicited by candidate human immunodeficiency virus type 1 vaccines. J. Virol. 79:10103-10107. doi:10.1128/JVI.79.16.10103- 10107.2005
35. Mascola, J.R., P. D'Souza, P. Gilbert, B.H. Hahn, N.L. Haigwood, L. Morris, C.J. Petropoulos, V.R. Polonis, M. Sarzotti, and D.C. Montefiori. 2005b. Recommendations for the design and use of standard virus panels to assess neutralizing antibody responses elicited by candidate human immunodeficiency virus type 1 vaccines. J. Virol. 79:10103-10107. doi:10.1128/JVI.79.16.10103- 10107.2005
36. Mason, L.J., A. Lambrianides, J.D. Haley, J.J. Manson, D.S. Latchman, D.A. Isenberg, and A. Rahman. 2005. Stable expression of a recombinant human antinucleosome antibody to investigate relationships between antibody sequence, binding properties, and pathogenicity. Arthritis Res. Ther. 7:R971-R983. doi:10.1186/ar1768
37. McNally, A.K., and J.M. Anderson. 1995. Interleukin-4 induces foreign body giant cells from human monocytes/macrophages. Differential lymphokine regulation of macrophage fusion leads to morphological variants of multinucleated giant cells. Am. J. Pathol. 147:1487-1499.
38. Montefiori, D.C. 2005. Evaluating neutralizing antibodies against HIV, SIV, and SHIV in luciferase reporter gene assays. Curr. Protoc. Immunol. 12:Unit 12.11.
39. Muster, T., F. Steindl, M. Purtscher, A. Trkola, A. Klima, G. Himmler, F. Rüker, and H. Katinger. 1993. A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1. J. Virol. 67:6642-6647.
40. Ochsenbauer, C.,and J.C. Kappes. 2009. New virologic reagents for neutralizing antibody assays. Curr Opin HIV AIDS. 4:418-425. doi:10.1086/508748
41. Pilgrim, A.K., G. Pantaleo, O.J. Cohen, L.M. Fink, J.Y. Zhou, J.T. Zhou, D.P. Bolognesi, A.S. Fauci, and D.C. Montefiori. 1997. Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection. J. Infect. Dis. 176:924-932. doi:10.1086/516508
42. Pitisuttithum, P., P. Gilbert, M. Gurwith, W. Heyward, M. Martin, F. van Griensven, D. Hu, J.W. Tappero, and K. Choopanya; Bangkok Vaccine Evaluation Group. 2006. Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand. J. Infect. Dis. 194:1661-1671. doi:10.1086/508748
43. Poignard, P., M. Moulard, E. Golez, V. Vivona, M. Franti, S. Venturini, M. Wang, P.W. Parren, and D.R. Burton. 2003. Heterogeneity of envelope molecules expressed on primary human immunodeficiency virus type 1 particles as probed by the binding of neutralizing and nonneutralizing antibodies. J. Virol. 77:353-365. doi:10.1128/JVI.77.1.353-365.2003
44. Radstake, T.R., R. van der Voort, M. ten Brummelhuis, M. de Waal Malefijt, M. Looman, C.G. Figdor, W.B. van den Berg, P. Barrera, and G.J. Adema. 2005. Increased expression of CCL18, CCL19, and CCL17 by dendritic cells from patients with rheumatoid arthritis, and regulation by Fc gamma receptors. Ann. Rheum. Dis. 64:359-367. doi:10.1136/ard.2003.017566
45. Ran, S., J. He, X. Huang, M. Soares, D. Scothorn, and P.E. Thorpe. 2005. Antitumor effects of a monoclonal antibody that binds anionic phospholipids on the surface of tumor blood vessels in mice. Clin. Cancer Res. 11:1551-1562. doi:10.1158/1078-0432.CCR-04-1645
46. Roben, P., J.P. Moore, M. Thali, J. Sodroski, C.F. Barbas III, and D.R. Burton. 1994. Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1. J. Virol. 68:4821-4828.
47. Sanders, R.W., M. Venturi, L. Schiffner, R. Kalyanaraman, H. Katinger, K.O. Lloyd, P.D. Kwong, and J.P. Moore. 2002. The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120. J. Virol. 76:7293-7305. doi:10.1128/JVI.76.14.7293-7305.2002
48. Sather, D.N., J. Armann, L.K. Ching, A. Mavrantoni, G. Sellhorn, Z. Caldwell, X. Yu, B. Wood, S. Self, S. Kalams, and L. Stamatatos. 2009. Factors associated with the development of cross-reactive neutralizing antibodies during human immunodeficiency virus type 1 infection. J. Virol. 83:757-769. doi:10.1128/JVI.02036-08
49. Scherl, M., U. Posch, G. Obermoser, C. Ammann, N. Sepp, H. Ulmer, M.P. Dierich, H. Stoiber, and B. Falkensammer. 2006. Targeting human immunodeficiency virus type 1 with antibodies derived from patients with connective tissue disease. Lupus. 15:865-872. doi:10.1177/0961203306071405
50. Schlame, M., and K.Y. Hostetler. 1997. Cardiolipin synthase from mammalian mitochondria. Biochim. Biophys. Acta. 1348:207-213.
51. Sekaly, R.-P. 2008. The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development? J. Exp. Med. 205:7-12. doi:10.1084/jem.20072681
52. Shen, X., R.J. Parks, D.C. Montefiori, J.L. Kirchherr, B.F. Keele, J.M. Decker, W.A. Blattner, F. Gao, K.J. Weinhold, C.B. Hicks, et al. 2009. In vivo gp41 antibodies targeting the 2F5 monoclonal antibody epitope mediate human immunodeficiency virus type 1 neutralization breadth. J. Virol. 83:3617-3625. doi:10.1128/JVI.02631-08
53. Soares, M.M., S.W. King, and P.E. Thorpe. 2008. Targeting inside-out phosphatidylserine as a therapeutic strategy for viral diseases. Nat. Med. 14:1357-1362. doi:10.1038/nm.1885
54. Stacey, A.R., P.J. Norris, L. Qin, E.A. Haygreen, E. Taylor, J. Heitman, M. Lebedeva, A. DeCamp, D. Li, D. Grove, et al. 2009. Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. J. Virol. 83:3719-3733. doi:10.1128/JVI.01844-08
55. Stiegler, G., R. Kunert, M. Purtscher, S. Wolbank, R. Voglauer, F. Steindl, and H. Katinger. 2001. A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1. AIDS Res. Hum. Retroviruses. 17:1757-1765. doi:10.1089/ 08892220152741450 (Pubitemid 34114213)
56. Tomaras, G.D., N.L. Yates, P. Liu, L. Qin, G.G. Fouda, L.L. Chavez, A.C. Decamp, R.J. Parks, V.C. Ashley, J.T. Lucas, et al. 2008. Initial B-cell responses to transmitted human immunodeficiency virus type 1: virionbinding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia. J. Virol. 82:12449-12463. doi:10.1128/JVI.01708-08
57. Tyler, D.S., H.K. Lyerly, and K.J. Weinhold. 1989. Anti-HIV-1 ADCC. AIDS Res. Hum. Retroviruses. 5:557-563. doi:10.1089/aid.1989.5.557
58. van de Wijgert, J.H., and R.J. Shattock. 2007. Vaginal microbicides: moving ahead after an unexpected setback. AIDS. 21:2369-2376. doi:10.1097/QAD.0b013e3282ef83fd
59. 2GP1 antibodies from two patients with antiphospholipid syndrome reveals three species of antibodies. Br. J. Haematol. 105:102-109. doi:10.1111/j.1365-2141.1999.01292.x
60. Zwick, M.B., A.F. Labrijn, M. Wang, C. Spenlehauer, E.O. Saphire, J.M. Binley, J.P. Moore, G. Stiegler, H. Katinger, D.R. Burton, and P.W. Parren. 2001. Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41. J. Virol. 75:10892-10905. doi:10.1128/JVI.75.22.10892-10905.2001